Results 11 to 20 of about 454,650 (72)
Tykhonov well-posedness of fixed point problems in contact mechanics
We consider a fixed point problem S u = u $\mathcal {S}u=u$ where S : C ( R + ; X ) → C ( R + ; X ) ${\mathcal {S}:C(\mathbb{R}_{+};X)\to C(\mathbb{R}_{+};X)}$ is an almost history-dependent operator.
M. Sofonea
semanticscholar +2 more sources
Vision-Language Pre-Training with Triple Contrastive Learning [PDF]
Vision-language representation learning largely benefits from image-text alignment through contrastive losses (e.g., InfoNCE loss). The success of this alignment strategy is attributed to its capability in maximizing the mutual information (MI) between ...
Jinyu Yang +8 more
semanticscholar +1 more source
CONVERGENCE CRITERIA, WELL-POSEDNESS CONCEPTS AND APPLICATIONS
We consider an abstract problem P in a metric space X which has a unique solution u G X. Our aim in this current paper is two folds: first, to provide a convergence criterion to the solution of Problem P , that is, to give necessary and sufficient ...
M. Sofonea, D. Tarzia
semanticscholar +1 more source
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Triple negative breast cancer (TNBC) has a negative expression of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptors (HER2).
O. Obidiro, G. Battogtokh, E. Akala
semanticscholar +1 more source
Tykhonov well-posedness of a viscoplastic contact problem†
We consider an initial and boundary value problem \begin{document}$ {{\mathcal{P}}} $\end{document} which describes the frictionless contact of a viscoplastic body with an obstacle made of a rigid body covered by a layer of elastic material.
M. Sofonea, Yi-bin Xiao
semanticscholar +1 more source
Spatial predictors of immunotherapy response in triple-negative breast cancer
Immune checkpoint blockade (ICB) benefits some patients with triple-negative breast cancer, but what distinguishes responders from non-responders is unclear^ 1 .
Xiao Qian Wang +26 more
semanticscholar +1 more source
Advances in immunotherapy for triple-negative breast cancer
Background Immunotherapy has recently emerged as a treatment strategy which stimulates the human immune system to kill tumor cells. Tumor immunotherapy is based on immune editing, which enhances the antigenicity of tumor cells and increases the ...
Yang Liu +8 more
semanticscholar +1 more source
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
BACKGROUND The addition of pembrolizumab to neoadjuvant chemotherapy led to a significantly higher percentage of patients with early triple-negative breast cancer having a pathological complete response (defined as no invasive cancer in the breast and ...
P. Schmid +29 more
semanticscholar +1 more source
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.
BACKGROUND In an interim analysis of this phase 3 trial, the addition of pembrolizumab to chemotherapy resulted in longer progression-free survival than chemotherapy alone among patients with advanced triple-negative breast cancer whose tumors expressed ...
J. Cortés +18 more
semanticscholar +1 more source
Pembrolizumab for Early Triple-Negative Breast Cancer.
BACKGROUND Previous trials showed promising antitumor activity and an acceptable safety profile associated with pembrolizumab in patients with early triple-negative breast cancer.
P. Schmid +20 more
semanticscholar +1 more source

